Bactericidal mode of action of bedaquiline

Journal of Antimicrobial Chemotherapy

Volumn 70, Issue 7, 2015, Pages 2028-2037

  Hards, Kiel ^a   Robson, Jennifer R ^a   Berney, Michael ^a,e   Shaw, Lisa ^a   Bald, Dirk ^b   Koul, Anil ^c   Andries, Koen ^c   Cook, Gregory M ^a,d  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b AMSTERDAM INSTITUTE FOR MOLECULES   (Netherlands)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Antimycobacterial agents; F1Fo ATP synthase; Mycobacteria; R207910; TMC207

Indexed keywords

ANTIMYCOBACTERIAL AGENT; BEDAQUILINE; GLYCEROL; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE;

ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL SUSPENSION; CELL VIABILITY; MEMBRANE POTENTIAL; MEMBRANE VESICLE; MICROARRAY ANALYSIS; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; NONHUMAN; OXYGEN CONSUMPTION; PROTON MOTIVE FORCE; REAL TIME POLYMERASE CHAIN REACTION; WHOLE CELL;

EID: 84936932059     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkv054     Document Type: Article

References (34)

1. Cook GM, Hards K, Vilchèze C et al. Energetics of respiration and oxidative phosphorylation inmycobacteria. In: Hatfull GF, Jacobs WR, eds. Molecular Genetics of Mycobacteria, 2nd edn. Washington, DC: ASM Press, 2014; 389-409.
2. Jones D. Tuberculosis success. Nat Rev Drug Discov 2013; 12: 175-6.
3. Koul A, Dendouga N, Vergauwen K et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol 2007; 3: 323-4.
4. Andries K, Verhasselt P, Guillemont J et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005; 307: 223-7.
5. De Jonge MR, Koymans LHM, Guillemont JEG et al. A computational model of the inhibition of Mycobacterium tuberculosis ATPase by a new drug candidate R207910. Proteins 2007; 67: 971-80.
6. Jensen PR, Michelsen O. Carbon and energy metabolism of ATP mutants of Escherichia coli. J Bacteriol 1992; 174: 7635-41.
7. Santana M, Ionescu MS, Vertes A et al. Bacillus subtilis F0F1 ATPase: DNA sequence of the ATP operon and characterization of ATP mutants. J Bacteriol 1994; 176: 6802-11.
8. Tran SL, Cook GM. The F1Fo-ATP synthase of Mycobacterium smegmatis is essential for growth. J Bacteriol 2005; 187: 5023-8.
9. Haagsma AC, Driessen NN, Hahn M-M et al. ATP synthase in slow-and fast-growing mycobacteria is active in ATP synthesis and blocked in ATP hydrolysis direction. FEMS Microbiol Lett 2010; 313: 68-74.
10. Koul A, Vranckx L, Dhar N et al. Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism. Nat Commun 2014; 5: 3369.
11. Frampton R, Aggio RBM, Villas-Bôas SG et al. Toxin-antitoxin systems of Mycobacterium smegmatis are essential for cell survival. J Biol Chem 2012; 287: 5340-56.
12. Tran SL, Rao M, Simmers C et al. Mutants of Mycobacterium smegmatis unable to grow at acidic pH in the presence of the protonophore carbonyl cyanide m-chlorophenylhydrazone. Microbiology 2005; 151: 665-72.
13. Rao SP, Alonso S, Rand L et al. The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2008; 105: 11945-50.
14. Rao M, Streur TL, Aldwell FE et al. Intracellular pH regulation by Mycobacterium smegmatis and Mycobacterium bovis BCG. Microbiology 2001; 147: 1017-24.
15. Formentini L, Sánchez-Aragó M, Sánchez-Cenizo L et al. The mitochondrial ATPase inhibitory factor 1 triggers a ROS-mediated retrograde prosurvival and proliferative response. Mol Cell 2012; 45: 731-42.
16. Martínez-Reyes I, Cuezva JM. The H(+)-ATP synthase: a gate to ROS-mediated cell death or cell survival. Biochim Biophys Acta 2014; 1837: 1099-112.
17. Koul A, Vranckx L, Dendouga N et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 2008; 283: 25273-80.
18. Cook GM, Greening C, Hards K et al. Energetics of pathogenic bacteria and opportunities for drug development. In: Poole RK, ed. Advances in Bacterial Pathogen Biology. Vol. 65 of Advances in Microbial Physiology. Academic Press, 2014; 1-62.
19. Nicholls DG, Ferguson SJ. The chemiosmotic proton circuit in isolated organelles: theory and practice. In: Bioenergetics, 4th edn. Academic Press, 2013; 53-87.
20. Kinoshita N, Unemoto T, Kobayashi H. Proton motive force is not obligatory for growth of Escherichia coli. J Bacteriol 1984; 160: 1074-7.
21. Snapper SB, Melton RE, Mustafa S et al. Isolation and characterization of efficient plasmid transformation mutants of Mycobacterium smegmatis. Mol Microbiol 1990; 4: 1911-9.
22. Kana BD, Weinstein EA, Avarbock D et al. Characterization of the cydAB-encoded cytochrome bd oxidase from Mycobacterium smegmatis. J Bacteriol 2001; 183: 7076-86.
23. Berney M, Weimar MR, Heikal A et al. Regulation of proline metabolism in mycobacteria and its role in carbon metabolism under hypoxia. Mol Microbiol 2012; 84: 664-81.
24. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg (Lond) 1938; 38: 732-49.
25. McKenzie JL, Robson J, Berney M et al. AVapBC toxin-antitoxin module is a posttranscriptional regulator of metabolic flux in mycobacteria. J Bacteriol 2012; 194: 2189-204.
26. Berney M, Cook GM. Unique flexibility in energy metabolism allows mycobacteria to combat starvation and hypoxia. PLoS One 2010; 5: e8614.
27. Hulsen T, de Vlieg J, Alkema W. BioVenn-a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 2008; 9: 488.
28. Pecsi I, Hards K, Ekanayaka N et al. Essentiality of succinate dehydrogenase in Mycobacterium smegmatis and its role in the generation of the membrane potential under hypoxia. MBio 2014; 5: e01093-14.
29. Greening C, Berney M, Hards K et al. A soil actinobacterium scavenges atmospheric H2 using two membrane-associated, oxygen-dependent [NiFe] hydrogenases. Proc Natl Acad Sci USA 2014; 111: 4257-61.
30. Matsoso LG, Kana BD, Crellin PK et al. Function of the cytochrome bc1-aa3 branch of the respiratory network in mycobacteria and network adaptation occurring in response to its disruption. J Bacteriol 2005; 187: 6300-8.
31. Cohen J. Approval of novel TB drug celebrated-with restraint. Science 2013; 339: 130.
32. Dhillon J, Andries K, Phillips PPJ et al. Bactericidal activity of the diarylquinoline TMC207 against Mycobacterium tuberculosis outside and within cells. Tuberculosis (Edinb) 2010; 90: 301-5.
33. Berney M, Hartman TE, Jacobs WR. A Mycobacterium tuberculosis cytochrome bd oxidase mutant is hypersensitive to bedaquiline. MBio 2014; 5: e01275-14.
34. Alavian KN, Beutner G, Lazrove E et al. An uncoupling channel within the c-subunit ring of the F1FO ATP synthase is the mitochondrial permeability transition pore. Proc Natl Acad Sci USA 2014; 111: 10580-5.